CR Medical Maintains Stable Share Capital Structure in October 2026 Monthly Return

Bulletin Express11-02

China Resources Medical Holdings Company Limited (CR Medical) filed its Monthly Return for the period ended 31 October 2026, confirming that both authorised and issued share capital remained unchanged during the month.

The authorised share capital stayed at 3.04 billion ordinary shares with a par value of HKD 0.00025 each, representing total authorised capital of HKD 0.76 million. Likewise, the issued share base was steady at 1.30 billion ordinary shares, with no treasury shares outstanding and no share issuances, repurchases, cancellations, or redemptions recorded for the month.

CR Medical affirmed compliance with Hong Kong’s 25% minimum public-float requirement as of 31 October 2026. The company reported no outstanding share options, warrants, convertible instruments, or other equity-linked agreements, indicating no imminent dilution risk from such securities.

The filing, submitted on 2 November 2026 by Company Secretary Chung Ming Fai, underscores the group’s consistent capital position and adherence to Hong Kong Stock Exchange listing rules throughout the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment